This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key building block in the creation of compounds targeting neurological disorders, such as depression and anxiety, due to its structural properties—including the methylsulfonyl and ethylamine groups—that interact with neurotransmitter systems. Additionally, it is employed in research settings for the development of novel therapeutic agents, especially those involving serotonin and dopamine modulation. Its application extends to the field of organic chemistry, where it is used in the preparation of complex molecules for drug discovery and development.